Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

ClinicalTrials.gov ID: NCT00455546

Public ClinicalTrials.gov record NCT00455546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PLASMA Trial: Phospholipase Levels And Serological Markers of Atherosclerosis: A Dose-Response Clinical Pharmacology Study of A-002 In Subjects With Stable Coronary Artery Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will be conducted at up to 80 centers worldwide and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 4 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.

Study identification

NCT ID
NCT00455546
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Anthera Pharmaceuticals
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2007 (Type not available)
Primary completion
Not listed
Completion
Sep 2007 (Type not available)
Last update posted
Feb 2, 2010

2007

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Mobile Heart Specialists Mobile Alabama 36608 —
Sonoran Health Specialists Scottsdale Arizona 85260 —
Central Arkansas Research Hot Springs Arkansas 71913 —
Broward General Medical Center Fort Lauderdale Florida 33316 —
Not listed Hudson Florida — —
Charlotte Cardiovascuar Research Port Charlotte Florida 339521 —
Florida Cardiovascular Institute Tampa Florida 33609 —
Augusta Cardiology Clinic, PC Augusta Georgia 30901 —
Louisville Cardiology Medical Group Louisville Kentucky 40207 —
Maine Research Associates Auburn Maine 04210 —
University of Michigan Ann Arbor Michigan 48106 —
Henry Ford Hospital Detroit Michigan 48202 —
United Medical Associates Binghamton New York 13901 —
Regional Clinical Research, Inc. Endwell New York 13760 —
Cardiology, PC Syracuse New York 13210 —
Oklahoma Cardiovascular and Hypertension Center Oklahoma City Oklahoma 73132 —
Lehigh Valley Hospital Allentown Pennsylvania 18105 —
Not listed Camp Hill Pennsylvania — —
Black Hills Clinical Research Center Rapid City South Dakota 57701 —
Austin Heart Austin Texas 78705 —
Cardiopulmonary Research Science and Technology Institute Dallas Texas 75230 —
Clinical Research Associates of Tidewater Norfolk Virginia 23507 —
Winsconin Heart, SC Madison Wisconsin 53715 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00455546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 2, 2010 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00455546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →